generic drugs

Generics Savings Continue, but Work RemainsGeneric drugs make up 90% of prescriptions.
Biosimilars Have Entered the Market, But Are They Safe?Biosimilars are starting to come on the market, but some have questions about their safety.
Retailers and PBMs Laud Generic/Biosimilar Savings
Retailers and PBMs Laud Generic/Biosimilar SavingsSavings from generic and biosimilar drugs are making PBMs and pharmacies, as well as patients, happy.
Biosimilars Come  to Community Pharmacy
Biosimilars Come to Community PharmacyBiosimilars are now being dispensed from community pharmacies.
Customers Sue CVS and Walgreens, Claiming PBM CollusionClass action lawsuits claim that chains colluded with PBMs to overbill customers.
Why Generic Drug Prices Are Dropping
Why Generic Drug Prices Are DroppingPharmacy chains are forcing lower generic prices for their customers.
Generics Market Expected to Explode in Next Five YearsThe U.S. market remains the largest single-country market in the world.
When Going the Extra Mile isn’t Enough
When Going the Extra Mile isn’t EnoughWhat do you do about the customer who is never satisfied?
What more transparency at the FDA means for health executivesResearchers create a set of recommendations for transparency at the agency in five principal areas.
Business Group Makes Price Recommendations for Specialty Drugs
Business Group Makes Price Recommendations for Specialty DrugsThe high cost of specialty drugs demands a change in Washington, according to a report.